Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.

Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.

Item
http://www.wikidata.org/entity/Q35951667
The effectiveness of risk communication regarding drug safety information: a nationwide survey by the Japanese public health insurance claims data.Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS)An investigation into the effect of advice from the Scottish Medicines Consortium on the use of medicines in Scotland's Health Service.Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.A critical review of methods to evaluate the impact of FDA regulatory actions.Impact of safety-related regulatory action on clinical practice: a systematic review.Methodological gaps in the assessment of risk minimization interventions: a systematic review.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Pharmacy students' knowledge of black box warnings.Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a countrywide study in Portugal.Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan.Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administration.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.Gastroenterologists' prescribing of infliximab for Crohn's disease: a national survey.
P2860

Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.

Item
http://www.wikidata.org/entity/Q35951667
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Impact of regulatory labeling ...... tate of Ohio medicaid program.
@ast
Impact of regulatory labeling ...... tate of Ohio medicaid program.
@en
type
label
Impact of regulatory labeling ...... tate of Ohio medicaid program.
@ast
Impact of regulatory labeling ...... tate of Ohio medicaid program.
@en
prefLabel
Impact of regulatory labeling ...... tate of Ohio medicaid program.
@ast
Impact of regulatory labeling ...... tate of Ohio medicaid program.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Impact of regulatory labeling ...... tate of Ohio medicaid program.
@en
P2093
P304
P31
P356
P433
P478
P577
P698